stoxline Quote Chart Rank Option Currency Glossary
  
Perrigo Company plc (PRGO)
25.55  -0.68 (-2.59%)    06-18 16:00
Open: 26.13
High: 26.36
Volume: 1,877,649
  
Pre. Close: 26.23
Low: 25.55
Market Cap: 3,483(M)
Technical analysis
2024-06-18 4:48:16 PM
Short term     
Mid term     
Targets 6-month :  33.89 1-year :  36.4
Resists First :  29.01 Second :  31.17
Pivot price 27.11
Supports First :  25.54 Second :  21.24
MAs MA(5) :  26.77 MA(20) :  27.45
MA(100) :  30.28 MA(250) :  31.72
MACD MACD :  -1 Signal :  -0.9
%K %D K(14,3) :  9 D(3) :  21.5
RSI RSI(14): 29.9
52-week High :  40.27 Low :  25.54
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ PRGO ] has closed below the lower bollinger band by 10.1%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 37% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 26.53 - 26.79 26.79 - 26.94
Low: 25 - 25.33 25.33 - 25.53
Close: 25.17 - 25.71 25.71 - 26.03
Company Description

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Headline News

Wed, 19 Jun 2024
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million - Quantisnow

Tue, 18 Jun 2024
Perrigo (NYSE:PRGO) Reaches New 52-Week Low at $25.70 - MarketBeat

Thu, 06 Jun 2024
Perrigo Company PLC (PRGO) Executive Vice President Buys 27900 in Shares - InvestorsObserver

Mon, 13 May 2024
Perrigo Company plc (NYSE:PRGO) Q1 2024 Earnings Call Transcript May 7, 2024 - Yahoo Finance

Tue, 07 May 2024
Perrigo Co PLC (PRGO) Q1 2024 Earnings: Adjusted EPS Exceeds Expectations Despite Sales Dip - Yahoo Finance

Tue, 07 May 2024
Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) Business - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 136 (M)
Shares Float 135 (M)
Held by Insiders 0.3 (%)
Held by Institutions 99.3 (%)
Shares Short 4,200 (K)
Shares Short P.Month 3,900 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 34.38
Profit Margin -0.2 %
Operating Margin 2.2 %
Return on Assets (ttm) 1.4 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth -8.4 %
Gross Profit (p.s.) 0
Sales Per Share 33.45
EBITDA (p.s.) 4.47
Qtrly Earnings Growth 0 %
Operating Cash Flow 385 (M)
Levered Free Cash Flow 465 (M)
Stock Valuations
PE Ratio 2555
PEG Ratio 1.2
Price to Book value 0.74
Price to Sales 0.76
Price to Cash Flow 9.05
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android